Evidence map›Paper›PMID 40624119›Full record

ArticleScientific reports2025

Aryl hydrocarbon receptor interacting protein and syndromic gene variants detected in Turkish isolated pituitary adenoma families by whole exome sequencing.

M Eda Ertorer, Feyza N Tuncer, Sema Ciftci, Seher Tanrikulu, Ozlem Soyluk Selcukbiricik, Ömercan Topaloğlu, Mehtap Evran, Pinar Kadioglu, Sevcan Aydin, Bulent Can and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

M Eda Ertorer *Division of Endocrinology and Metabolism, Baskent University Faculty of Medicine, Adana, Turkey.
Feyza N Tuncer *Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey. ftuncer@istanbul.edu.tr.
Sema CiftciDivision of Endocrinology and Metabolism, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Seher TanrikuluDivision of Endocrinology and Metabolism, Acibadem Atasehir Hospital, Istanbul, Turkey.
Ozlem Soyluk SelcukbiricikDivision of Endocrinology and Metabolism, Istanbul University Faculty of Medicine, Istanbul, Turkey.
Ömercan TopaloğluDivision of Endocrinology and Metabolism, Zonguldak Bulent Ecevit University Faculty of Medicine, Zonguldak, Turkey.
Mehtap EvranDivision of Endocrinology and Metabolism, Cukurova University Faculty of Medicine, Adana, Turkey.
Pinar KadiogluDivision of Endocrinology and Metabolism, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey.
Sevcan AydinGraduate School of Health Sciences, Istanbul University, Istanbul, Turkey.
Bulent CanDivision of Endocrinology and Metabolism, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey.
Canan SehitDivision of Endocrinology and Metabolism, Erciyes University Faculty of Medicine, Kayseri, Turkey.
Zafer PekkolayDivision of Endocrinology and Metabolism, Dicle University Faculty of Medicine, Diyarbakir, Turkey.
Guzide Gonca OrukDivision of Endocrinology and Metabolism, İzmir Katip Çelebi Üniversitesi Atatürk Eğitim Ve Araştırma Hastanesi, İzmir, Turkey.
Berrin CetinarslanDivision of Endocrinology and Metabolism, Kocaeli University Faculty of Medicine, Kocaeli, Turkey.
Sema YarmanDivision of Endocrinology and Metabolism, Istanbul University Faculty of Medicine, Istanbul, Turkey. sema.yarman@gmail.com.

Funding

Society of Endocrinology and Metabolism of Turkey 2021/P03
6 · The paper itself

Abstract

Genetic causes of familial isolated pituitary adenomas (FIPAs) remain mostly elusive. A cohort of 20 FIPA cases from 12 different geographical regions of Türkiye was included to characterize clinical and genetic features. Whole exome sequencing (WES) was performed on genomic DNA of index cases, followed by confirmation through Sanger sequencing utilizing indexes and their relatives to interpret disease associated variants. Index cases among homogeneous (n = 10) and heterogeneous (n = 10) FIPA groups (45% female /55% male), age at diagnosis was 36.3 ± 11.98 years, median follow-up was 103 months. GH-secreting adenomas dominated homogeneous group (60% vs. 30% of heterogeneous group). Two predefined AIP variants [p.(Arg304Ter) and p.(Arg81Ter)] and a novel AIP variant at splice acceptor site [(c.646-1G > C)] were detected in three families (15%). Syndromic heterozygous novel NF1 [p.(Thr1295Ala)], TSC1 [p.(Arg517Gln)], SDHB [p.(Glu176Gly)] and CDH23 [p.(Ala765Val)] variants were detected in four FIPA families, along with novel candidate genes in the remaining patients of the cohort. Among all detected variants, three [p.(Arg81Ter) and (c.646-1G > C) in AIP, and p.(Glu216GlysfsTer61) in TINF2] were classified as pathogenic according to ACMG. AIP mutation frequency was 15% in our cohort. A novel AIP variant, and novel variations in syndromic genes were identified, along with the introduction of candidate genes. WES method is a crucial approach to identify new rare genetic variants in familial settings, and it will pave the way for future studies on targeted therapies.

Indexed as

AdenomaGrowth Hormone-Secreting Pituitary AdenomaIntracellular Signaling Peptides and ProteinsPituitary NeoplasmsAdultExome SequencingFemaleGenetic Predisposition to DiseaseHumansMaleMiddle AgedMutationPedigreeTurkeyaryl hydrocarbon receptor-interacting proteinIntracellular Signaling Peptides and ProteinsAIPFIPAsNovel variantsSyndromic genesWhole exome sequencing

Identifiers

PMID40624119
PMCPMC12234825

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.